GSK
GSK
GSK
635 hedge funds and large institutions have $13.5B invested in GSK in 2013 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 235 increasing their positions, 228 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
1% less funds holding
Funds holding: 639 → 635 (-4)
2% less capital invested
Capital invested by funds: $13.8B → $13.5B (-$303M)
7% less funds holding in top 10
Funds holding in top 10: 14 → 13 (-1)
Holders
635
Holding in Top 10
13
Calls
$174M
Puts
$87.3M
Top Buyers
| 1 | +$127M | |
| 2 | +$71.9M | |
| 3 | +$58.7M | |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$25.9M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$24.6M |
Top Sellers
| 1 | -$232M | |
| 2 | -$149M | |
| 3 | -$62.8M | |
| 4 |
Berkshire Hathaway
Omaha,
Nebraska
|
-$56.7M |
| 5 |
Bank of New York Mellon
New York
|
-$37.9M |